LNAI on Nasdaq

Lunai Bioworks Inc.

American pharmaceutical preparations company based in Los Angeles. Summary from the record

$0.89 down 0.00 (0.20%)Price as of Oct 15, 2026 at 17:33 UTC

Last updated Oct 19, 2026.

Overview

$52.0KRevenue, fiscal 20264
-$3.6MNet income, fiscal 20264

Compare with Arena Pharmaceuticals, HCW Biologics Inc. or TENAX THERAPEUTICS, INC., or pick any stock.

  • TickerLNAI on Nasdaq2
  • IndustryPharmaceutical Preparations2
  • HeadquartersCopenhagen, Denmark2
  • Incorporated inDE5
  • Business addressCentury City Medical Plaza, 2080 Century City East, Suite 906 Los Angeles, Ca 900675
  • Filer categoryNon-accelerated filer, Smaller reporting company5
  • Legal formCorporation2
  • LEI5493003O12Q6PNJ56V392
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O Vcorp Services, LLC, 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 49289002

See how the biggest companies compare on our leaderboards

Our ability to continue as a going concern and ability to raise additional capital;6 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

-16729.4%Operating margin4
-6852.0%Net margin4
-$5.3MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Research and development47¢$24.5K
  • Other costs50¢$26.1K
  • Income tax3¢$1.4K

Out of $52.0K in revenue.4 The company lost money this year.

Financial statements

Operating income7891011124-$8.7M in 2026−21% since 2019
-$200.0M-$150.0M-$100.0M-$50.0M02019: -$11.0M-$11.0M20192020: -$11.9M-$11.9M2020+8%2021: -$23.4M-$23.4M2021+96%2022: -$116.1M-$116.1M2022+396%2023: -$38.6M-$38.6M2023−67%2024: -$81.6M-$81.6M2024+112%2025: -$189.0M-$189.0M2025+131%2026: -$8.7M-$8.7M2026−95%
Net income7891011124-$3.6M in 2026−80% since 2019
-$200.0M-$150.0M-$100.0M-$50.0M02019: -$18.0M-$18.0M20192020: -$11.4M-$11.4M2020−37%2021: -$26.7M-$26.7M2021+134%2022: -$113.4M-$113.4M2022+324%2023: -$39.7M-$39.7M2023−65%2024: -$88.4M-$88.4M2024+123%2025: -$178.0M-$178.0M2025+101%2026: -$3.6M-$3.6M2026−98%
Fiscal year20192020202120222023202420252026
Revenue$52.0K4
Cost of revenue
Gross profit
Research and development$2.5M7$4.7M8$15.7M9$8.4M10$4.2M11$2.7M12$537.4K4$24.5K4
Operating expenses$116.1M10$38.6M11$81.6M12$189.0M4$8.7M4
Operating income-$11.0M7-$11.9M8-$23.4M9-$116.1M10-$38.6M11-$81.6M12-$189.0M4-$8.7M4
Interest$437$104.3K8$379.6K9$372.8K9
Income before tax-$113.4M10-$39.7M10
Income tax-$125.3K9$3410$012$1.5K4$1.4K4
Net income-$18.0M7-$11.4M8-$26.7M9-$113.4M10-$39.7M11-$88.4M12-$178.0M4-$3.6M4
Earnings per share-$2.1610-$0.7111-$0.9112-$86.274-$1.064
Earnings per share (diluted)-$2.1610-$0.7111-$0.9112-$86.274-$1.064
Shares (weighted, basic)52.5M shares1056.3M shares1197.5M shares122.1M shares43.4M shares4
Shares (weighted, diluted)52.5M shares1056.3M shares1197.5M shares122.1M shares43.4M shares4

Compare Lunai Bioworks Inc. with another company

Leadership

Who has led Lunai Bioworks Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Eric Jean Marie Leire2014–2017
  2. Mark Dybul2021–2024
  3. David Hershel Weinstein2024

Chair

  1. Niels Erik Nielsen2014

President

  1. Eric Jean Marie Leire2014

Chief financial officer

  1. Sasha S. Masri2011
  2. Lone Degn2015
  3. Luisa Puche2019–2024
  4. Simon Tarsh2024
  5. Nathen Fuentes2025

Chief operating officer

  1. Francois Binette2024
201520202025
Board members and other officers (29)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • DirectorAvram Miller named Feb 23, 202451

Former names

  • RENOVARO INC.Jan 30, 2024 to Aug 26, 20255
  • RENOVARO BIOSCIENCES INC.Jun 9, 2023 to Feb 7, 20245
  • Enochian Biosciences IncMar 6, 2018 to Aug 1, 20235
  • DanDrit Biotech USA, Inc.Feb 14, 2014 to Feb 23, 20185
  • Putnam Hills Corp.Aug 12, 2011 to Feb 11, 20145

Timeline

  1. Oct 29, 2024New chief executive David Hershel Weinstein becomes CEO16
  2. Jul 22, 2021New chief executive Mark Dybul becomes CEO17
  3. Feb 21, 2014New chief executive Eric Jean Marie Leire becomes CEO18
  4. Jan 18, 2011Founded Lunai Bioworks Inc. is founded2

Filings

336 filings to the SEC since October 2021: 9 annual reports, 18 quarterly reports, 103 major events, 101 insider forms, 42 large holders, 1 private raises, 62 other. The latest 20:

  1. Oct 15, 2026SCHEDULE 13D/A EDGAR
  2. Oct 13, 202610-K EDGAR
  3. Oct 9, 20268-K EDGAR
  4. Sep 29, 2026NT 10-K EDGAR
  5. Jul 17, 2026SCHEDULE 13G EDGAR
  6. Jun 17, 20268-K EDGAR
  7. Jun 16, 20268-K EDGAR
  8. May 20, 20268-K EDGAR
  9. May 15, 202610-Q EDGAR
  10. May 13, 20268-K EDGAR
  11. May 11, 20268-K/A EDGAR
  12. May 1, 2026DEFR14A EDGAR
  13. May 1, 20268-K EDGAR
  14. Apr 28, 20268-K EDGAR
  15. Apr 28, 2026DEFA14A EDGAR
  16. Apr 15, 2026DEFR14A EDGAR
  17. Apr 13, 2026DEF 14A EDGAR
  18. Apr 2, 2026PRE 14A EDGAR
  19. Mar 30, 20268-K EDGAR
  20. Mar 5, 20268-K EDGAR

The 336 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

19 open-market trades by officers, directors and large owners since October 2021: 1 buys and 18 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 29, 2024William Anderson Wittekind10% ownerSale1,114$1.30$1.4KForm 4
Jul 17, 2024William Anderson Wittekind10% ownerSale16,362$1.46$23.9KForm 4
Jul 15, 2024William Anderson Wittekind10% ownerSale21,954$1.41$31.0KForm 4
Jul 11, 2024William Anderson Wittekind10% ownerSale14,896$1.51$22.5KForm 4
Jul 10, 2024William Anderson Wittekind10% ownerSale75,000$1.51$113.2KForm 4
Jul 9, 2024William Anderson Wittekind10% ownerSale4,630$1.53$7.1KForm 4
Jul 5, 2024William Anderson Wittekind10% ownerSale60,000$1.55$93.0KForm 4
Jul 3, 2024William Anderson Wittekind10% ownerSale50,000$1.51$75.5KForm 4
Jul 2, 2024William Anderson Wittekind10% ownerSale34,553$1.54$53.2KForm 4
Jul 1, 2024William Anderson Wittekind10% ownerSale60,000$1.56$93.6KForm 4
Jun 27, 2024William Anderson Wittekind10% ownerSale14,671$1.50$22.0KForm 4
Jun 26, 2024William Anderson Wittekind10% ownerSale50,000$1.57$78.5KForm 4
Jun 25, 2024William Anderson Wittekind10% ownerSale20,000$1.58$31.6KForm 4
Jun 14, 2024William Anderson Wittekind10% ownerSale50,000$1.58$79.0KForm 4
May 18, 2022Gumrukcu Serhat10% ownerSale253,493$8.00$2.0MForm 4
May 18, 2022Sindlev ReneDirectorBuy253,493$8.00$2.0MForm 4
Mar 22, 2022Sandler Carl ForestSale1,927$9.06$17.5KForm 4
Feb 23, 2022Sandler Carl ForestSale6$9.00$54Form 4
Feb 18, 2022Sandler Carl ForestSale6,792$9.03$61.3KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Feb 13, 2024Raised $106.8 million in a private offering of equity Form D: 8 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Ground Swell Capital, LLC53,211$174.0K0.2%New
Geode Capital Management, LLC24,156$79.0K0.0%New
Jane Street Group, LLC23,683$77.4K0.0%New
Vanguard Capital Management LLC16,081$52.6K0.0%New
BlackRock, Inc.15,906$52.0K0.0%New
Vanguard Fiduciary Trust Co8,642$28.3K0.0%New
Royal Bank Of Canada1,687$5.0K0.0%New
Tower Research Capital LLC (TRC)1,405$4.6K0.0%New
Group One Trading LLC544$1.8K0.0%New
Morgan Stanley326$1.1K0.0%New
Compass Financial Management LLC125$4090.0%New
Bnp Paribas Financial Markets24$780.0%New
Virtu Financial LLC12,863$420.0%New
Jpmorgan Chase & Co6$190.0%New
Deutsche Bank Ag\1$30.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
    Yahoo FinanceLNAI quote
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56